Mechanisms of Cisplatin nephrotoxicity.
Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. · 2010
Read Mechanisms of Cisplatin nephrotoxicity. by Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3153174.txt.
Description
Ronald Miller and colleagues reviewed how a leading cancer drug damages kidneys in a 2010 paper in Toxins. The platinum drug cures or controls many cancers of the head, lung, ovary, and testis, but kidney injury limits how much can be given. A decade of work had uncovered much of the cell-level story, which the review gathers.
The drug enters kidney tubule cells and triggers several death routes at once, while injured cells spark inflammation that deepens the damage. Acute kidney injury strikes a sizable share of patients. Understanding the chain, from drug uptake to cell death signals to immune amplification, points to targeted shields that might protect kidneys without weakening the drug's attack on tumours.
Catalog record
| CREATOR | Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 88 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |